Literature DB >> 24496177

OAT3-mediated extrusion of the 99mTc-ECD metabolite in the mouse brain.

Tatsuya Kikuchi1, Toshimitsu Okamura1, Hidekatsu Wakizaka2, Maki Okada1, Kenichi Odaka1, Joji Yui1, Atsushi B Tsuji3, Toshimitsu Fukumura1, Ming-Rong Zhang1.   

Abstract

After administration of the (99m)Tc complex with N,N'-1,2-ethylenediylbis-L-cysteine diethyl ester ((99m)Tc-ECD), a brain perfusion imaging agent, the radioactive metabolite is trapped in primate brain, but not in mouse and rat. Here, we investigate the involvement of metabolite extrusion by organic anion transporter 3 (OAT3), which is highly expressed at the blood-brain barrier in mice, in this species difference. The efflux rate of radioactivity in the cerebrum of Oat3(-/-) mice at later phase was 20% of that of control mice. Thus, organic anion transporters in mouse brain would be involved in the low brain retention of radioactivity after (99m)Tc-ECD administration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24496177      PMCID: PMC3982094          DOI: 10.1038/jcbfm.2014.20

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

Review 1.  Confounding parameters in preclinical assessment of blood-brain barrier permeation: an overview with emphasis on species differences and effect of disease states.

Authors:  Anand K Deo; Frank-Peter Theil; Jean-Marie Nicolas
Journal:  Mol Pharm       Date:  2013-01-04       Impact factor: 4.939

2.  Metabolism of technetium-99m-L,L-ethyl cysteinate dimer in rat and cynomolgus monkey tissue.

Authors:  Y Inoue; T Momose; T Ohtake; J Nishikawa; Y Sasaki; T Waritani; M Inoue
Journal:  J Nucl Med       Date:  1997-11       Impact factor: 10.057

3.  [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives.

Authors:  R A Koeppe; K A Frey; G K Mulholland; M R Kilbourn; A Buck; K S Lee; D E Kuhl
Journal:  J Cereb Blood Flow Metab       Date:  1994-01       Impact factor: 6.200

4.  Cellular basis of ECD brain retention.

Authors:  M R Jacquier-Sarlin; B S Polla; D O Slosman
Journal:  J Nucl Med       Date:  1996-10       Impact factor: 10.057

5.  Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates.

Authors:  R C Walovitch; T C Hill; S T Garrity; E H Cheesman; B A Burgess; D H O'Leary; A D Watson; M V Ganey; R A Morgan; S J Williams
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

6.  Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction.

Authors:  B L Holman; R S Hellman; S J Goldsmith; I G Mena; J Leveille; P G Gherardi; J L Moretti; A Bischof-Delaloye; T C Hill; P M Rigo
Journal:  J Nucl Med       Date:  1989-06       Impact factor: 10.057

7.  Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.

Authors:  Sumio Ohtsuki; Tazuru Kikkawa; Shinobu Mori; Satoko Hori; Hitomi Takanaga; Masaki Otagiri; Tetsuya Terasaki
Journal:  J Pharmacol Exp Ther       Date:  2004-02-04       Impact factor: 4.030

8.  Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.

Authors:  Sumio Ohtsuki; Hiroshi Asaba; Hitomi Takanaga; Tsuneo Deguchi; Ken-ichi Hosoya; Masaki Otagiri; Tetsuya Terasaki
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

9.  Metabolism of 99mTc-L,L-ethyl cysteinate dimer in healthy volunteers.

Authors:  R C Walovitch; M Franceschi; M Picard; E H Cheesman; K M Hall; J Makuch; M W Watson; R E Zimmerman; A D Watson; M V Ganey
Journal:  Neuropharmacology       Date:  1991-03       Impact factor: 5.250

10.  Studies of the retention mechanism of the brain perfusion imaging agent 99mTc-bicisate (99mTc-ECD).

Authors:  R C Walovitch; E H Cheesman; L J Maheu; K M Hall
Journal:  J Cereb Blood Flow Metab       Date:  1994-01       Impact factor: 6.200

View more
  3 in total

Review 1.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

2.  Mechanisms of glutathione-conjugate efflux from the brain into blood: Involvement of multiple transporters in the course.

Authors:  Toshimitsu Okamura; Maki Okada; Tatsuya Kikuchi; Hidekatsu Wakizaka; Ming-Rong Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-22       Impact factor: 6.200

3.  Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo.

Authors:  Hiroya Kuwahara; Jindong Song; Takahiro Shimoura; Kie Yoshida-Tanaka; Tadahaya Mizuno; Tatsuki Mochizuki; Satoshi Zeniya; Fuying Li; Kazutaka Nishina; Tetsuya Nagata; Shingo Ito; Hiroyuki Kusuhara; Takanori Yokota
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.